Hypothalamic NUCKS regulates peripheral glucose homoeostasis.

Area of Science:

• Metabolic research
• Neuroendocrinology
• Molecular biology

Background:

• Nuclear ubiquitous casein and cyclin-dependent kinase substrate (NUCKS) is highly expressed in the brain and metabolic organs.
• NUCKS regulates genes involved in insulin signaling.
• Whole-body NUCKS depletion (NKO) in mice causes obesity, glucose intolerance, and insulin resistance.

Purpose of the Study:

• To investigate the tissue-specific role of NUCKS in metabolic regulation, focusing on the hypothalamus.
• To determine the function of hypothalamic NUCKS in controlling peripheral glucose metabolism and insulin signaling.

Main Methods:

• Generated mice with hypothalamus-specific NUCKS deletion (HNKO) using Cre-lox technology.
• Assessed glucose tolerance, insulin tolerance, and metabolic parameters in HNKO and control mice on normal chow and high-fat diets.
• Investigated the effect of NUCKS on insulin receptor levels in the brain and compared HNKO mice with immune-cell-specific NUCKS deletion (VNKO) mice.

Main Results:

• Hypothalamic insulin signaling was impaired in NKO mice.
• HNKO mice exhibited mild glucose intolerance on a normal diet and exacerbated obesity and insulin resistance on a high-fat diet.
• NUCKS deletion in immune cells (VNKO) did not lead to obesity or insulin resistance phenotypes.
• NUCKS was found to regulate brain insulin receptor levels.

Conclusions:

• Hypothalamic NUCKS is essential for maintaining glucose homeostasis and insulin signaling in vivo.
• NUCKS plays a critical role in the brain's regulation of metabolic processes.
• Tissue-specific deletion studies highlight the importance of hypothalamic NUCKS in preventing diet-induced obesity and insulin resistance.